From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer
Jiangang Sun,1,* Xiaojing Li,2,* Peng Chen,1 Yongshun Gao1 1Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China; 2Department of Pharmacy, the First Affiliated Hospital of Zhengzhou Un...
Saved in:
Main Authors: | Sun J (Author), Li X (Author), Chen P (Author), Gao Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2
by: Bo-Wei Wang, et al.
Published: (2021) -
Present and future of breast cancer anti-Her-2-therapy
by: V. P. Letyagin
Published: (2014) -
Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021) -
<i>FGFR1</i> Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
by: María Gaibar, et al.
Published: (2022) -
Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells
by: Mashan L. Abdullah, et al.
Published: (2018)